Infliximab: A Novel Treatment Option for Refractory Orofacial Granulomatosis
Wiebke K. Peitsch, Nicole Kemmler, Sergij Goerdt, Matthias Goebeler*
DOI: 10.2340/00015555-0219
Abstract
This article does not have an abstract.
Significance
Supplementary content
Comments
